U.S. Physical Therapy, Inc.
General ticker "USPH" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $1.2B (TTM average)
U.S. Physical Therapy, Inc. does not follow the US Stock Market performance with the rate: -10.4%.
Estimated limits based on current volatility of 2.3%: low 78.49$, high 82.12$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-08-21, amount 0.46$ (Y2.21%)
- Total employees count: 7294 (+3.8%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Medicare reimbursement, Regulatory and compliance, Billing errors and penalties, Physician reliance, Therapist retention issues
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [66.76$, 97.25$]
- 2026-12-31 to 2027-12-31 estimated range: [69.53$, 100.90$]
Financial Metrics affecting the USPH estimates:
- Positive: with PPE of 30.7 at the end of fiscal year the price was neutral
- Positive: 7.80 < Operating profit margin, % of 11.10
- Positive: 4.90 < Operating cash flow per share per price, % of 6.16
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share per price, % of 0.78 <= 1.42
- Positive: 3.66 < Industry operating cash flow per share per price (median), % of 4.90
- Positive: 34.41 < Shareholder equity ratio, % of 39.57 <= 42.26
- Positive: 3.48 < Return on assets ratio (scaled to [-100,100]) of 4.60
- Positive: -4.55 < Industry operating profit margin (median), % of -0.34
Short-term USPH quotes
Long-term USPH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $604.80MM | $671.35MM | $780.99MM |
| Operating Expenses | $552.74MM | $608.35MM | $694.31MM |
| Operating Income | $52.06MM | $62.99MM | $86.68MM |
| Non-Operating Income | $-2.69MM | $-2.79MM | $-8.86MM |
| Interest Expense | $9.30MM | $8.02MM | $9.46MM |
| Income(Loss) | $49.38MM | $60.21MM | $77.81MM |
| Taxes | $12.16MM | $14.61MM | $19.81MM |
| Net Income(Loss)* | $28.24MM | $31.42MM | $39.58MM |
| Stockholders Equity | $476.19MM | $488.93MM | $476.43MM |
| Assets | $997.24MM | $1,167.47MM | $1,204.01MM |
| Operating Cash Flow | $81.98MM | $74.94MM | $75.06MM |
| Capital expenditure | $9.29MM | $9.19MM | $14.07MM |
| Investing Cash Flow | $-45.02MM | $-149.45MM | $-36.71MM |
| Financing Cash Flow | $84.27MM | $-36.95MM | $-44.14MM |
| Earnings Per Share** | $1.99 | $2.09 | $2.61 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.